Global Biodefense Market is valued at USD 13.43 Billion in 2020 and is expected to reach USD 20.47 Billion by 2027 with a CAGR of 6.2% over the forecast period.
The presence of favorable government initiatives, increasing investment by the governments in developed countries, and growing threat of terrorism across the globe are some of the major factors driving the growth of the Global Biodefense Market.
Download Free Exclusive Sample (200 Pages PDF) Report @:
Scope of Global Biodefense Market Report:
Biodefense is a system of planned actions to counter and reduce the risk of biological threats and to prepare, respond to, and recover from them if they happen. Biodefense involves the development of capabilities and knowledge to assess, detect, monitor, respond to, and attribute biological threats. Biodefense is frequently discussed in the context of Bioware or bioterrorism and is generally considered a military or emergency response term.
Biodefense applies to two distinct target populations: civilian non-combatant and military combatants (troops in the field). Biodefense uses medical measures to protect people against bioterrorism. This includes medicines and vaccinations. It also includes medical research and preparations to defend against bioterrorist attacks. It is technically possible to apply biodefense measures to protect animals or plants, but this is generally uneconomic.
The key players of Global Biodefense Market are such as Cleveland BioLabs, Bavarian Nordic, Ichor Medical Systems, SIGA Technologies, Xoma Corporation, Achaogen, Inc., Emergent BioSolutions, Inc., DynPort Vaccine Company, LLC, Elusys Therapeutics, Inc., Dynavax Technologies Corporation, PharmAthene, Inc. and other.
Global Biodefense Industry Segmentation:
- Medical Hygiene
- National Defense
Get Methodology of the Biodefense Market Report @:
News: Pandemic Experts Launched the American Biodefense Institute
On June 25th, 2020; America’s top pandemic and biosecurity leaders announced the launch of the American BioDefense Institute, a Washington DC-based think tank that will offer research and advisory to the United States Congress, Federal Agency, and NGO space.
A Notable Uptick in Bioterrorism Attack is Mainly Driving the Global Biodefense Market
As Bioterrorism & other high consequence, biological events can result in issues such as epidemic illness, mass casualties, healthcare worker illness, environmental contamination, legal issues. It causes unease within the community and also in the medical community at large. Also, the bioterrorist attack has a lot in common with naturally occurring public health emergencies resulting from infectious diseases. So the biodefense has high demand as it cashes in on medical measures and uses vaccinations and medicines against bioterrorist attacks.
In addition, the presence of a significant number of key biodefense agencies such as the Defense (DOD), Departments of Homeland Security (DHS), Agriculture (USDA), Health and Human Services (HHS), and the Environmental Protection Agency in many regions across the globe are supplementing the market growth. These agencies conduct a wide range of activities for developing biological threat awareness for intentional & naturally occurring threats and report using that information to support investment decisions.
Furthermore, favorable government initiatives are also fostering market growth. For instance; The National Biodefense Analysis and Countermeasures Center (NBACC) is the first national laboratory created by the Department of Homeland Security. This NBACC reports unmet needs in homeland security & provides a continuously available national security, biocontainment laboratory capability for newly identified biological threats. This is also fueling the growth of the global biodefense market.
North America is Expected to Dominate the Global Biodefense Market
The global biodefense market is segmented into North America, Europe, Asia- Pacific Latin America and Middle East & Africa. North America is expected to dominate the global biodefense market due to the presence of high federal funding and technological advancements in this region. For instance; according to Federal Research and Development (R&D) Funding, in FY2017, about 8 federal agencies has received about 96.3% of total federal R&D funding, with the Department of Defense (39.3%) and the Department of Health and Human Services (27.3%) combined accounting for more than two-thirds of all federal R&D funding in the United States.
President Trump’s FY2019 budget is largely silent on funding levels for a number of multiagency R&D initiatives for biodefense. Also, the National Biodefense Strategy is aligned with the 2018 National Security Strategy of the United States. This strategy is to detect and contain biothreats at their source, support and promote biomedical innovation, and improve emergency response in case of biological outbreaks. Such government initiatives are driving the market for biodefense into this region.
Asia Pacific is expected to witness the fastest growth in the global biodefense market due to surging investments in R&D, the growing significance of biodefense, and the rising threat of harmful biological materials that produce emergencies in this region. There is growing investment in R&D for biodefense in the Asia Pacific region and Australia and Japan are two of the most established markets for biodefense in the region as there are well-established vaccines R&D and production facilities in these countries. Along with that, the presence of sophisticated healthcare infrastructure in the country contributes to its market position.
Global Biodefense Market Analysis and Forecast, By Regional Analysis
- Rest of Europe
- South Korea
- Rest Of APAC
Rest of South America
- Middle East and Africa
- Saudi Arabia
- South Africa
- Rest Of MEA
Buy Now @
This comprehensive report will provide:
- Enhance your strategic decision making
- Assist with your research, presentations, and business plans
- Show which emerging market opportunities to focus on
- Increase your industry knowledge
- Keep you up-to-date with crucial market developments
- Allow you to develop informed growth strategies
- Build your technical insight
- Illustrate trends to exploit
- Strengthen your analysis of competitors
- Provide risk analysis, helping you avoid the pitfalls other companies could make
- Ultimately, help you to maximize profitability for your company.
Our Market Research Solution Provides You Answer to Below Mentioned Question:
- Which are the driving factors responsible for the growth of the market?
- Which are the roadblock factors of this market?
- What are the new opportunities, by which market will grow in coming years?
- What are the trends of this market?
- Which are the main factors responsible for new product launches?
- How big are the global & regional markets in terms of revenue, sales, and production?
- How far will the market grow in the forecast period in terms of revenue, sales, and production?
- Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
- How will each segment grow over the forecast period and how much revenue will these segments account for in 2028?
- Which region has more opportunities?
Key Benefits of Global Biodefense Industry Report
- Global Biodefense Industry report covers in-depth historical and forecast analysis.
- Global Biodefense Industry research report provides detailed information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Biodefense Companies, Regional and Country Level.
- Global Biodefense Industry report helps to identify opportunities in marketplace.
- Global Biodefense Industry report covers an extensive analysis of emerging trends and competitive landscape.
Get Access to the Full Report Here:
The Global Surgical Instrument Tracking Systems Market in terms of revenue was worth of USD 193.8 Million in 2021 and is Projected to reach USD 513.1 Million by 2028, growing at a CAGR of 14.92% from 2021 to 2027.
Animal Vaccine Market was worth of USD 11.13 billion in 2021 and it is expected to reach 20.48 billion by the end of 2028 with the CAGR of 9.1% during Forecast Period.
Hemophilia Gene Therapy Market is valued at USD 331.4 Million in 2021 and expected to reach USD 4092.6 Million by 2028 with a CAGR of 43.2% over the forecast period.
Global Bioinformatics Market in terms of revenue was worth of USD 10.82 Billion in 2021 and expected to reach USD 24.07 Billion by 2028, growing at a CAGR of 12.1% from 2021 to 2028.
Colorectal Cancer Market is valued at USD 11.83 Billion in 2021 and is expected to reach USD 16.21 Billion by 2028 with a CAGR of 5.40% over the forecast period.
Global Medical Tricorder Market is valued at USD 3425.4 Million in 2021 and is expected to reach USD 5411.2 Million by 2028 with a CAGR of 6.75% over the forecast period.
Global Healthcare CRM Market is valued at USD 12.53 Billion in 2021 and is expected to reach USD 31.54 Billion by 2028 with a CAGR of 14.1% over the forecast period.
The Global Metaverse in Healthcare Market is valued at USD 5056.4 Million in 2021 and is expected to reach USD 7453.6 Million by 2028 with a CAGR of 33.7% over the forecast period.
Global Demand For Advanced Wound Care Market, in terms of revenue, was estimated to be USD 9.01 billion in 2018 and is expected to reach USD 13.27 billion in 2025, growing at a CAGR of 5.85% from 2019 to 2025.
According to Brandessence Market Research latest research study says Global demand for biophotonics market size in terms of revenue, was worth of USD 53.28 Billion in 2020. The biophotonics market is likely to reach USD 109.23 Billion by 2027 end, growing at a robust 10.8% CAGR.
The Global Sterility Testing Market in terms of revenue was worth of USD 1036.13 Million in 2021 and expected to reach USD 2193.8 Million by 2028, growing at a CAGR of 12.6% from 2021 to 2028.
i-Factor: Live Market intelligence platform
I-Factor is our guaranteed seal to keep our clients ahead of the competition, always. This knowledge platform delivers real-time updates on key economic indicators, competitive landscape, changing demand, trends, customized regional insights, and more. The platform visualizes key data points to help make decision making agile, trustworthy, and holistic. Register for free trial here at https://brandessenceresearch.com/i-factor/login/userRegister
Brandessence Market Research & Consulting Pvt ltd.
Brandessence Market Research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.